Abstract
In the survey conducted in 2014, among the 10,802 Japanese medical institutions receiving blood supply from the Japanese Red Cross Blood Center, the 5,434 institutions that responded to the questionnaire, were enrolled, representing a response ratio of 50.66%, the highest result in the past 7 years. Of the total supply from the Japanese Red Cross Society, 74.50% of the red blood cell products, 81.47% of the platelet concentrate, and 77.98% of the freshly frozen plasma were able to be investigated. Institutions authorized to impose the blood transfusion management charge I and II increased in 472 and 1,189 institutions, respectively. In addition, 1,159 institutions were able to impose the blood transfusion proper use addition (26.2%). The number of transfused patients is predicted to be 10% down in total, 22.3% in autologous blood, and 8.7% in donated blood, compared with the previous fiscal year. Only immunoglobulin products consumption increased this year. The amount of blood products consumed per one sickbed showed large variation by each prefecture, suggesting the need to strengthen cooperation between combined blood transfusion therapy committees in each prefecture in order to assess success rate for proper blood transfusion.
